CYduct Diagnostics, Inc. (CYDX)
OTCMKTS · Delayed Price · Currency is USD
2.701
+0.151 (5.93%)
At close: Jan 16, 2026
CYduct Diagnostics Market Cap
CYduct Diagnostics has a market cap or net worth of $14.16 million as of January 20, 2026. Its market cap has increased by 206.80% in one year.
Market Cap
14.16M
Enterprise Value
n/a
Revenue
344.78K
Ranking
n/a
PE Ratio
103.71
Stock Price
$2.70
Market Cap Chart
Since October 21, 2009, CYduct Diagnostics's market cap has increased from 13.69M to 14.16M, an increase of 3.39%. That is a compound annual growth rate of 0.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 14.16M | 1,675.94% |
| Dec 27, 2024 | 797.13K | -69.60% |
| Dec 11, 2023 | 2.62M | -49.00% |
| Dec 29, 2021 | 5.14M | 66.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |